Clinitech Laboratory Ltd vs Galaxy Medicare Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Clinitech Laboratory Ltd is ₹ 32 as of 07 Oct 15:30 . The P/E Ratio of Clinitech Laboratory Ltd is 23.3 as of March 2025 .The P/E Ratio of Galaxy Medicare Ltd is 0 as of March 2025 . The Market Cap of Clinitech Laboratory Ltd is ₹ 9.18 crore as of March 2025 .The Market Cap of Galaxy Medicare Ltd is ₹ 0 crore as of March 2025 . The Dividend Payout of Clinitech Laboratory Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Galaxy Medicare Ltd changed from 9.72 % on March 2021 to 31.05 % on March 2026 . This represents a CAGR of 21.36% over 6 years .

About Clinitech Laboratory Ltd

Clinitech Laboratory Limited was incorporated as Clinitech Laboratory Private Limited on March 19, 2010 with the Registrar of Companies, Mumbai.
The status of Company was changed to Public Limited and the name of Company changed to Clinitech Laboratory Limited through fresh certificate of incorporation upon conversion on August 25, 2023 was issued by the Registrar of Companies, Mumbai.
Company is in the business of healthcare services providing superior quality services such as pathology testing laboratories, diagnostic centers, scan centers, X-ray and ECG clinics, etc. The Company established a new Lab in Kalyan in 2012, NABL Accreditation at Airoli Centre in 2016, a new Lab at Thane in 2018.
Besides these, the Company conduct more than 150 tests including Biochemistry, Immunology, Hematology, Molecular Biology tests, urine analysis, Serology, Microbiology and Histopathology tests.

About Galaxy Medicare Ltd

Galaxy Medicare Limited was originally established on July 23, 1992 as a Limited Company in the Mancheshwar Industrial area of Bhubaneswar, Orissa.
The Company commenced its operations in 1992 when the founder, Mr. Dillip Kumar Das, acquired a closed business unit, M/s Cure Aids Private Limited from Odisha Industrial Infrastructure Development Corporation (IDCO) and Odisha State Financial Corporation under the investment promotion, facilitation and aftercare strategy of Industrial Promotion and Investment Corporation of Odisha (IPICOL) and revived the business unit to start manufacturing of Medical Devices such as Plaster of Paris Bandage (POP Bandage), Medical Tapes and Bandages, Other surgical dressings and external preparations products of Wound care & Wound management including sterile surgical wound dressing, medical disposable, adhesive bandages, absorbent gauze, etc.

FAQs for the comparison of Clinitech Laboratory Ltd and Galaxy Medicare Ltd

Which company has a larger market capitalization, Clinitech Laboratory Ltd or Galaxy Medicare Ltd?

Market cap of Clinitech Laboratory Ltd is 7 Cr while Market cap of Galaxy Medicare Ltd is 27 Cr

What are the key factors driving the stock performance of Clinitech Laboratory Ltd and Galaxy Medicare Ltd?

The stock performance of Clinitech Laboratory Ltd and Galaxy Medicare Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Clinitech Laboratory Ltd and Galaxy Medicare Ltd?

As of October 25, 2026, the Clinitech Laboratory Ltd stock price is INR ₹32.0. On the other hand, Galaxy Medicare Ltd stock price is INR ₹18.05.

How do dividend payouts of Clinitech Laboratory Ltd and Galaxy Medicare Ltd compare?

To compare the dividend payouts of Clinitech Laboratory Ltd and Galaxy Medicare Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.